Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Health Catalyst, Inc - Common stock (NQ: HCAT )

5.620 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.620
Bid (Size) 5.300 (9)
Ask (Size) 5.660 (2)
Prev. Close 5.620
Today's Range 5.620 - 5.620
52wk Range 5.320 - 10.31
Shares Outstanding 46,602,775
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Data Analytics Stocks Q3 Highlights: Domo (NASDAQ:DOMO)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the data analytics stocks, including Domo (NASDAQ:DOMO) and its peers. 
Via StockStory
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire

Performance

YTD
-23.38%
-23.38%
1 Month
-24.05%
-24.05%
3 Month
-27.58%
-27.58%
6 Month
-5.23%
-5.23%
1 Year
-41.52%
-41.52%

More News

Read More
A Look Back at Data Analytics Stocks’ Q3 Earnings: Palantir (NASDAQ:PLTR) Vs The Rest Of The Pack
Via StockStory
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Breaking Down Health Catalyst: 8 Analysts Share Their Views
Via Benzinga
The Latest Analyst Ratings For Health Catalyst
Via Benzinga
What Analysts Are Saying About Health Catalyst Stock
Via Benzinga
Winners And Losers Of Q3: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks
Via StockStory
Q3 Data Analytics Earnings Review: First Prize Goes to Samsara (NYSE:IOT)
Via StockStory
Futures Slump As Yields, Dollar Soar
Via Talk Markets
Topics Commodities Stocks / Equities
Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks
Via StockStory
Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts
Via Benzinga
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
Via Benzinga
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
Topics Stocks
Exposures US Equities
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
Earnings To Watch: Domo (DOMO) Reports Q3 Results Tomorrow
Via StockStory
What To Expect From Samsara’s (IOT) Q3 Earnings
Via StockStory
Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Health Catalyst to Participate in Upcoming Investor Conferences
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst (NASDAQ:HCAT) Posts Q3 Sales In Line With Estimates
Via StockStory
Health Catalyst Reports Third Quarter 2024 Results
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst (HCAT) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Health Catalyst to Announce Third Quarter 2024 Operating Results and Host Conference Call on Wednesday, November 6, 2024
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst to Participate in Upcoming Investor Conferences
From Health Catalyst, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.